SCHEMBL6885296

SCHEMBL6885296

CCCCCCc1ccc2cc3ccccc3cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.54
CYP1A2 P05177 2/20 0.52
CYP2A6 P11509 1/20 0.52
GPR3 P46089 1/20 0.51
BCHE P06276 2/20 0.51
HDAC1 Q13547 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
ESR1 P03372 2/20 0.48
ADRA2A P08913 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
TACR2 P21452 2/20 0.48
SLC6A2 P23975 2/20 0.48
SLC6A4 P31645 2/20 0.48
SLC6A3 Q01959 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
SHBG P04278 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3355324 1.00 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL4048750 1.00 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL22288179 1.00 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL6889827 1.00 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL5011068 1.00 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL4759062 1.00 SIGMAR1 (0.54) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL2360369 0.98 SIGMAR1 (0.56) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL598951 0.94 SIGMAR1 (0.61) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL11515396 0.94 SIGMAR1 (0.61) SIGMAR1CYP1A2CYP2A6GPR3BCHE
SCHEMBL9299473 0.94 SIGMAR1 (0.61) SIGMAR1CYP1A2CYP2A6GPR3BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118619805-A Method for efficiently purifying 2-alkylanthracene in anthracene alkylation product 杭州澜通科技有限公司 2024-09-10 CN claimed
CN-117986105-A Separation method of 2-alkylanthraquinone, 2-alkylanthraquinone product prepared by separation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN claimed
CN-117945874-A Method for separating 2-alkylanthraquinone from 2-alkylanthracene oxidation reaction liquid, refined 2-alkylanthraquinone and application thereof 中国石油化工股份有限公司 2024-04-30 CN claimed
CN-117945875-A Method for separating 2-alkylanthraquinone, 2-alkylanthraquinone product prepared by the method and application thereof 中国石油化工股份有限公司 2024-04-30 CN claimed
CN-100456518-C Organic thin film transistor and method for manufacturing the same 3M INNOVATIVE PROPERTIES CO (US) 2009-01-28 CN claimed
CN-1639884-A Organic thin film transistor with improved gate dielectric surface 3M INNOVATIVE PROPERTIES CO (US) 2005-07-13 CN claimed
EP-1481428-A1 ORGANIC THIN FILM TRANSISTOR WITH MODIFIED SURFACE OF GATE-DIELECTRIC 3M Innovative Properties Company (US) 2004-12-01 EP claimed
US-6768132-B2 MULTILAYER INTEGRATED CIRCUIT; BARRIER DIELECTRIC AND SEMICONDUCTOR 3M INNOVATIVE PROPERTIES COMPANY 2004-07-27 US claimed
US-20030175551-A1 Surface modified organic thin film transistors 3M INNOVATIVE PROPERTIES COMPANY 2003-09-18 US claimed
WO-2003077327-A1 ORGANIC THIN FILM TRANSISTORS WITH MODIFIED SURFACE OF GATE-DIELECTRIC 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-09-18 WO claimed
US-12391633-B2 Method for separating 2-alkylanthracenes and use thereof for producing hydrogen peroxide CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2025-08-19 US disclosed
CN-118619805-A Method for efficiently purifying 2-alkylanthracene in anthracene alkylation product 杭州澜通科技有限公司 2024-09-10 CN disclosed
CN-114436797-B Preparation method of 2-alkylanthraquinone 中国石油化工股份有限公司 2024-05-17 CN disclosed
CN-114436796-B Preparation method of 2-alkylanthraquinone 中国石油化工股份有限公司 2024-05-17 CN disclosed
CN-117986105-A Separation method of 2-alkylanthraquinone, 2-alkylanthraquinone product prepared by separation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN disclosed
EP-1481428-A1 ORGANIC THIN FILM TRANSISTOR WITH MODIFIED SURFACE OF GATE-DIELECTRIC 3M Innovative Properties Company (US) 2004-12-01 EP disclosed
US-6768132-B2 MULTILAYER INTEGRATED CIRCUIT; BARRIER DIELECTRIC AND SEMICONDUCTOR 3M INNOVATIVE PROPERTIES COMPANY 2004-07-27 US disclosed
US-20030175551-A1 Surface modified organic thin film transistors 3M INNOVATIVE PROPERTIES COMPANY 2003-09-18 US disclosed
WO-2003077327-A1 ORGANIC THIN FILM TRANSISTORS WITH MODIFIED SURFACE OF GATE-DIELECTRIC 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-09-18 WO disclosed
US-4052205-A POLYVINYL CARBAZOLE XEROX CORPORATION (US) 1977-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12391633-B2 Method for separating 2-alkylanthracenes and use thereof for producing hydrogen peroxide AKR7A2, HAO2, HACL2 SIGMAR1 3922/4885CYP1A2 6/4885CYP2A6 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.